[Retracted] Presepsin Predicts Severity and Secondary Bacterial Infection in COVID-19 by Bioinformatics Analysis

Table 1

Comprehensive literature list.

Year	Country	Literature
2022	South Korean	Predictive values of procalcitonin and presepsin for acute; Kidney injury and 30-day hospital mortality in patients with COVID-19
2021	Egypt	Presepsin as a novel biomarker in predicting inhospital mortality in patients with COVID-19 pneumonia
2021	South Korea	Presepsin and monocyte distribution width as a useful early biomarker of severity in patients with COVID-19
Between October 2020 and July 2021	Pakistan	Diagnostic value of novel presepsin and inflammatory biomarkers in predicting the clinical course of COVID-19
2021	Turkey	The role of presepsin in predicting severe coronavirus disease 2019 pneumonia prognosis
2021	Japan	Simultaneous daily platelet count and presepsin measurement from the time of ICU admission may be useful for predicting inhospital mortality of patients with severe COVID-19
2020	Italy	A simple prognostic score based on troponin and presepsin for COVID-19 patients admitted to the emergency department: a single-center pilot study
2021	Japan	Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression
2020	Japan	Presepsin as a predictive biomarker of severity in COVID-19: a case series